Raphaël Boisgard Selected Research

Raphaël Boisgard Research Topics

Disease

11	Neoplasms (Cancer) 11/2016 - 03/2005
7	Neuroinflammatory Diseases 01/2018 - 08/2011
5	Breast Neoplasms (Breast Cancer) 02/2016 - 06/2011
3	Brain Ischemia (Cerebral Ischemia) 03/2017 - 01/2010
2	Inflammation (Inflammations) 02/2016 - 09/2012
2	Carcinogenesis 01/2016 - 04/2007
2	Carcinoma (Carcinomatosis) 07/2015 - 04/2007
2	Ischemia 02/2011 - 01/2010
2	Stroke (Strokes) 02/2011 - 01/2010
2	Liver Neoplasms (Liver Cancer) 09/2008 - 04/2007
2	Hepatocellular Carcinoma (Hepatoma) 09/2008 - 04/2007
1	Seizures (Absence Seizure) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Epilepsy (Aura) 01/2018
1	Temporal Lobe Epilepsy 01/2018
1	Brain Neoplasms (Brain Tumor) 02/2016
1	Hypoxia (Hypoxemia) 07/2015
1	Glioma (Gliomas) 12/2013
1	Disease Progression 12/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2012
1	Myelitis 04/2012
1	Melanoma (Melanoma, Malignant) 04/2011
1	Diabetes Insipidus 07/2007
1	Thyroid Neoplasms (Thyroid Cancer) 04/2007
1	Cholangiocarcinoma 04/2007
1	Neoplasm Metastasis (Metastasis) 07/2006
1	Adenocarcinoma 07/2006
1	Colorectal Neoplasms (Colorectal Cancer) 07/2006

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2005
7	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 03/2017 - 01/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 07/2007
4	GABA-A Receptors (GABA(A) Receptor)IBA 09/2012 - 01/2010
3	LigandsIBA 09/2015 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2011
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 03/2017 - 08/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2016 - 11/2013
2	Fluorine-18IBA 09/2015 - 03/2014
2	acetamideIBA 12/2013 - 01/2010
2	Contrast MediaIBA 11/2013 - 07/2006
1	Kainic Acid (Kainate)IBA 01/2018
1	CB2 Cannabinoid ReceptorIBA 03/2017
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 03/2017
1	CannabinoidsIBA 03/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2016
1	Hematoxylin (Haematoxylon)IBA 11/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Oncogene Proteins (Oncogene Protein)IBA 01/2016
1	PyrimidinesIBA 09/2015
1	Sunitinib (Sutent)FDA Link 07/2015
1	Phosphotransferases (Kinase)IBA 07/2015
1	fluoromisonidazoleIBA 07/2015
1	Phenobarbital (Luminal)FDA Link 07/2015
1	N,N- diethyl- 2- (2- (4- (3- fluoropent- 1- yn- 1- yl)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 03/2014
1	Glial Fibrillary Acidic ProteinIBA 12/2013
1	erucylphospho- N,N,N- trimethylpropylammoniumIBA 12/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2013
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 11/2013
1	Hormones (Hormone)IBA 11/2013
1	SteroidsIBA 11/2013
1	Myelin Basic ProteinIBA 04/2012
1	AntibodiesIBA 06/2011
1	Radioisotopes (Radionuclides)IBA 04/2011
1	Neuroprotective AgentsIBA 02/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2011
1	Minocycline (Cyclops)FDA LinkGeneric 02/2011
1	PolynucleotidesIBA 09/2008
1	Pancreatitis-Associated ProteinsIBA 09/2008
1	Messenger RNA (mRNA)IBA 04/2007
1	IodidesIBA 04/2007
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 04/2007
1	SymportersIBA 04/2007
1	sodium-iodide symporter (sodium iodide symporter)IBA 04/2007
1	GlycosphingolipidsIBA 07/2006

Therapy/Procedure

6	Therapeutics 07/2015 - 07/2006
2	Radiotherapy 09/2008 - 04/2007
1	Treatment Delay 01/2016
1	Drug Therapy (Chemotherapy) 01/2016
1	Injections 07/2006